Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion type Assertion NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_head.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion description "[In familial cutaneous malignant melanoma (CMM), disruption of the retinoblastoma (pRB) pathway frequently occurs through inactivating mutations in the p16 (p16INK4A/CDKN2A/MTS1) gene or activating mutations in the G1-specific cyclin dependent kinase 4 gene (CDK4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_provenance.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion evidence source_evidence_literature NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_provenance.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion SIO_000772 10732752 NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_provenance.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion wasDerivedFrom befree-2016 NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_provenance.
- NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_assertion wasGeneratedBy ECO_0000203 NP278868.RAPPXo-ByfL7fp9lmij-btJNvHR4PTaCIzQpS03R2VQKw130_provenance.